Planet 13 Holdings (PLNH) Income towards Parent Company (2021 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Income towards Parent Company of -$8.1 million for Q1 2026, down 180.63% year-over-year from $10.0 million in Q1 2025, and down 215.53% quarter-over-quarter from $7.0 million in Q4 2025.
Planet 13 Holdings (PLNH) Income towards Parent Company (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Income towards Parent Company for 6 consecutive years, with -$8.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Income towards Parent Company fell 180.63% year-over-year to -$8.1 million; the TTM figure through Mar 2026 stood at -$58.3 million (down 80.37% YoY), while the FY2025 annual figure was -$52.3 million, down 46.87% from the prior year.
- Income towards Parent Company fell to -$8.1 million in Q1 2026 per PLNH's latest filing, from $7.0 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at $7.0 million in Q4 2025 and bottomed at -$46.3 million in Q3 2023.
- Historically, Income towards Parent Company has averaged -$13.6 million across 5 years, with a median of -$8.1 million in 2024.
- Annual changes were most pronounced in 2022 — Income towards Parent Company tumbled 2136.41% — and 2025, when it jumped 149.18%.
- Planet 13 Holdings' Income towards Parent Company stood at -$44.0 million in 2022, then soared by 67.6% to -$14.3 million in 2023, then increased by 0.07% to -$14.2 million in 2024, then surged by 149.18% to $7.0 million in 2025, then plunged by 215.53% to -$8.1 million in 2026.
- Business Quant data shows PLNH's Income towards Parent Company at -$8.1 million in Q1 2026, $7.0 million in Q4 2025, and -$44.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Planet 13 Holdings | 47.95 Mn | 31.46 Mn | 12.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.59 Mn |
| Mar 31, 2026 | -8.10 Mn |
| Dec 31, 2025 | 7.01 Mn |
| Sep 30, 2025 | -43.96 Mn |
| Jun 30, 2025 | -13.30 Mn |
| Mar 31, 2025 | -2.88 Mn |
| Dec 31, 2024 | -14.25 Mn |
| Sep 30, 2024 | -7.14 Mn |
| Jun 30, 2024 | -8.07 Mn |
| Mar 31, 2024 | -5.89 Mn |
| Dec 31, 2023 | -14.26 Mn |
| Sep 30, 2023 | -46.25 Mn |
| Jun 30, 2023 | -4.66 Mn |
| Mar 31, 2023 | -8.48 Mn |
| Dec 31, 2022 | -44.01 Mn |
| Sep 30, 2022 | -6.34 Mn |
| Jun 30, 2022 | -7.09 Mn |
| Mar 31, 2022 | -4.07 Mn |
| Dec 31, 2021 | -12.46 Mn |
| Sep 30, 2021 | 4.05 Mn |